Psychiatrists' documentation of informed consent: A representative survey

Canadian Journal of Psychiatry

Volumn 51, Issue 7, 2006, Pages 438-444

  Schachter, Debbie ^a,b,c   Kleinman, Irwin ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

Antipsychotic medication; Documentation; Health record; Informed consent

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; MALE; MEDICAL DOCUMENTATION; MEDICAL PRACTICE; PSYCHIATRIST; QUESTIONNAIRE; SELF REPORT;

EID: 33746024326     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370605100705     Document Type: Article

References (30)

1. Grisso T, Appelbaum PS. Assessing competence to consent to treatment. A guide for physicians and other health professionals. New York (NY): Oxford University Press; 1998.
2. Reibl v Huges. 2 Supreme Court Reports 880 (S. Ct. of Canada 1980).
3. Dickens BM. Informed consent. In: Downie J, Caulfield T, Flood C, editors. Canadian health law and policy, 2nd ed. Markham (ON): Butterworths; 2002. p129-56.
4. Hopp v Lepp. 2 Supreme Court Reports 192 (S. Ct. of Canada 1980).
5. Schachter D, Kleinman I, Prendergast P, Remington G, Schertzer S. The effect of psychopathology on the ability of schizophrenic patients to give informed consent. J Nerv Ment Dis 1994;182:360-2.
6. Grisso T, Appelbaum PS. The MacArthur Treatment Competence Study. III. Abilities of patients to consent to psychiatric and medical treatments. Law Hum Behav 1995;19:149-74.
7. Abidi S, Bhaskara SM. From chlorpromazine to clozapine - antipsychotic adverse effects and the clinician's dilemma. Can J Psychiatry 2003;48:749-55.
8. Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. Am J Psychiatry 1980;137:1163-72.
9. Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 1987;39:473-81.
10. Laugharne J, Davies A, Arcelus J, Bouman WP. Informing patients about tardive dyskinesia: a survey of clinicians' attitudes in three countries. Int J Law Psychiatry 2004;27:101-8.
11. Schachter D, Kleinman I. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia. Psychiatr Serv 2004;55:714-7.
12. Jaffe R. Informed consent: recall about tardive dyskinesia. Compr Psychiatry 1981;22;434-7.
13. Kleinman I, Schachter D, Koritar E. Informed consent and tardive dyskinesia. Am J Psychiatry 1989;146:902-4.
14. Munetz MR, Roth LH. Informing patients about tardive dyskinesia. Arch Gen Psychiatry 1985;42:866-71.
15. Robinson G, Merav A. Informed consent: recall by patients tested postoperatively. Ann Thorac Surg 1976;22:209-12.
16. American Psychiatric Association. Task Force Report 18. Tardive dyskinesia. Washington (DC): American Psychiatric Association; 1979.
17. Sovner R, DiMascio A, Berkowitz D, Randolph P. Tardive dyskinesia and informed consent. Psychosomatics 1978;19:172-7.
18. Munetz MR, Peterson GA. Documenting informed consent for treatment with neuroleptics; an alternative to the consent form. Psychiatr Serv 1996;47:302-3.
19. Lacro JP, Sewell DD, Warren K, Woody S, Harris MJ, Jeste DP. Improving documentation of consent for neuroleptic therapy. Hosp Comm Psychiatry 1994;45:176-8.
20. Schachter D, Kleinman I. Psychiatrists' documentation of informed consent. Can J Psychiatry 1998;43:1012-7.
21. Cortese L, Jog M, McAuley TJ, Kotteda V, Costa G. Assessing and monitoring antipsychotic-induced movement disorders in hospitalized patients: a cautionary study. Can J Psychiatry 2004;49(1):31-6.
22. Borgiel AEM, Williams JI, Bass MJ, Dunn EV, Evenson MK, Lamont CT, and others. Quality of care in family practice: does residency training make a difference? CMAJ 1989;140:1035-43.
23. Crowne D, Marlowe D. A new scale of social desirability independent of psychopathology. J Consult Psychol 1960;24:349-54.
24. Faden RR, Lewis C, Becker C, Faden AI, Freeman J. Disclosure standards and informed consent. J Health Polit Policy Law 1981;6:255-84.
25. Hamann J, Langer B, Leucht S, Busch R, Kissling W. Medical decision making in antipsychotic drug choice for schizophrenia. Am J Psychiatry 2004;161:1301-4.
26. Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatr Serv 1997;48:1415-9.
27. Hammond KW, Snowden M, Risse SC, Adkins TG, O'Brien JJ. An effective computer-based tardive dyskinesia monitoring system. Am J Med Quality 1995;10:133-7.
28. Luo J, Hales RE, Servis H, Gill M. Clinical computing: use of personal digital assistants in consultation psychiatry. Psychiatr Serv 2002;53:271-9.
29. Baker JG, Shanfield SB, Schnee S. Using quality improvement teams to improve documentation in records at a community mental health center. Psychiatr Serv 2000;51:239-42.
30. Wisner KL, Zarin DA, Holmboe ES, Appelbaum PS, Gelenberg AJ, Leonard HL, and others. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000;157:1933-40.